Table 2.
Characteristics | ABI ≤1.0 n = 261 |
ABI > 1.0 n = 2080 |
P Valuea |
---|---|---|---|
CCL-21, pg/mL | 902 ± 293 | 789 ± 271 | < .001 |
E-cadherin, ng/mL | 238 ± 80 | 222 ± 62 | .003 |
HGF, pg/mL | 1,054 ± 260 | 973 ± 250 | < .001 |
ICAM-1, ng/mL | 266 ± 108 | 258 ± 118 | .30 |
IL-2sr, pg/mL | 808 ± 453 | 707 ± 327 | < .001 |
L-selectin, ng/mL | 876 ± 208 | 895 ± 194 | .16 |
MMP-1, ng/mL | 6.2 ± 4.6 | 5.5 ± 4.1 | .02 |
MMP-2, ng/mL | 198 ± 31 | 195 ± 31 | .16 |
P-selectin, ng/mL | 31 ± 9.3 | 29 ± 9.2 | .002 |
RANTES, pg/mL | 4,933 ± 5081 | 4,211 ± 3,892 | .03 |
SDF-1α, pg/mL | 1,982 ± 480 | 1,935 ± 441 | .11 |
SLPI, pg/mL | 49,755 ± 12853 | 45,775 ± 10,457 | < .001 |
TGFβ-1, pg/mL | 4,259 ± 2431 | 3,911 ± 2,284 | .02 |
TIMP-2, ng/mL | 82 ± 12 | 81 ± 12 | .05 |
VCAM-1, ng/mL | 768 ± 222 | 728 ± 222 | .008 |
Abbreviations: ABI, ankle-brachial index; CCL21, chemokine ligand 21; HGF, hepatocyte growth factor; ICAM-1, intercellular adhesions molecule 1; IL-2SR, interleukin 2 soluble receptor; MMP-1, matrix metalloproteinase 1; MMP-2, matrix metalloproteinase 2; RANTES, regulated on activation normal T cell expressed and secreted; SDF-1α, stromal derived factor 1α; SLPI, secretory leukocyte protease inhibitor; TGFβ-1, transforming growth factor; TIMP-2, tissue inhibitor of metalloproteinases 2; VCAM-1, vascular cell adhesion molecule 1.
P Values by t-test or Wilcoxon test as appropriate.